Staff

TOP 5 publications:

1. Hart X, Amann F, Brand J, Eichentopf L, Gründer G. Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study.Pharmacopsychiatry. 2023 56(2):73-80.
2. Hart XM, Amann F, Baumann P, Havemann-Reinecke U, Schoretsanitis G, Steimer W, Unterecker S, Zernig G, Gründer G, Hiemke C. How to Determine a Therapeutic Reference Range for a Psychotropic Drug Systematically? Recommendations of the TDM Task Force of the AGNP.Ther Drug Monit. 2025 47(2):199-210. Epub 2025 Feb 14.
3. Amann F, Hefner G, Cremer-Schaeffer P, Gründer G, Häuser W, Hart XM, Petzke F, Zernig G, Havemann-Reinecke U. Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone.Pharmacopsychiatry. 2026 Jun 10. [Epub ahead of print].